Compound α-Ketoacid Granules( Fresenius Kabi Pharma)

复方α-酮酸颗粒（费森尤斯卡比医药）

Report date: 2025/10/23 09:49:32

Base Information

Drug NameCompound α-Ketoacid Granules( Fresenius Kabi Pharma)
Drug Alias Name复方α-酮酸颗粒（2.2类改良型）
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAmino acid replacementsCarbonic anhydrase I activators
TargetsCarbonic anhydrase I
Therapy Area/IndicationsRenal Insufficiency, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Compound α -ketoic acid
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesBeijing Fresenius Kabi Pharmaceutical Company Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Fresenius Kabi Pharmaceutical Company Ltd
Inactive CompaniesN/A
Active IndicationsRenal Insufficiency, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A